@article{manzolaro_prismap_2023,
	title = {{PRISMAP} Deliverable D8.1 - Proceedings book workshop 1},
	rights = {Creative Commons Attribution 4.0 International, Open Access},
	url = {https://zenodo.org/record/7913190},
	doi = {10.5281/ZENODO.7913190},
	abstract = {This deliverable is the Proceedings book of the {PRISMAP} workshop 1 “{PRISMAP} workshop on emerging infrastructures and technical developments”. The Workshop on Emerging Infrastructures and Technical Developments was organised at Legnaro National Laboratories on 21-24 November 2022. The Workshop gave a general update on international facilities producing radionuclides, identified the most promising radionuclides on which production R\&D shall focus in the near future, and presented the latest technical developments on targets, ion sources and mass separation techniques. This is one of the two events organised within the {WP}8: Involvement of Emerging Infrastructures. The workshop was organised in a hybrid format, registering 76 participants, out of which 39 in person and 37 remotely. The first day of the workshop included 15 talks dedicated to infrastructures and radionuclides programmes. The second day was dedicated to more technical topics, including 9 technical talks covering the major activities performed within {WP}10: on targets, ion sources and isotopes purification. The on-site participants could join a visit to {SPES} facilities, enjoying a unique opportunity to enter all sections of this {ISOL} facility which is getting ready to start the beam commissioning. Furthermore, a poster session has been organised, where 9 posters have been presented. Proceedings contributions from some of the posters are included in this Book of Proceedings.},
	author = {Manzolaro, Mattia and Corradetti, Stefano and Pupillo, Gaia and Popescu, Lucia},
	urldate = {2023-05-30},
	date = {2023-05-09},
	langid = {english},
	note = {Publisher: Zenodo
Version Number: 1},
	keywords = {biomedical research facilities, deliverable, high power cyclotrons, high purity isotopes, high purity radionuclides, isotope mass separation facilities, mass separation, nuclear reactors, radiopharmaceuticals},
}